news & events

Patient interview: Seamus Cotter

Patient interview: Seamus Cotter

We interviewed Seamus Cotter from Ireland about his experiences with immunotherapy. Seamus has stage IV NSCLC lung cancer, was diagnosed in June 2016, and is now in remission. We asked him how he found out about immunotherapy, which treatment he received, and what his...

Meet the partner: Lygature

Meet the partner: Lygature

Within Immune-Image, Lygature co-leads the data management work package, WP2, taking overall responsibility for the timely delivery of the deliverables and milestones in the various subtasks and the creation and execution of the data management plan. It is Lygature's...

Meet the person behind the researcher: Claudia Foray

Meet the person behind the researcher: Claudia Foray

Claudia Foray is a researcher for the Immune-Image project and is involved in the project because of the focus of her PhD project. In her research she tries to understand therapy-induced modification of the tumor microenvironment in glioma models using molecular...

Interview Conny van der Laken

Interview Conny van der Laken

Conny van der Laken is a rheumatologist and a principal investigator of advanced imaging studies in rheumatology at the University of Amsterdam. Within the Immune-Image project, she is leader of Task 6.5, in a work package linked to patient research. Her research...

Immune-Image 2nd annual meeting 27, 28, 29 September

Immune-Image 2nd annual meeting 27, 28, 29 September

Two years after the start date of the Immune Image project its second annual meeting will be held. The Immune-Image consortium consists of 22 partner institutes and over 125 scientists key players from across 9 countries. Collectively they bring extensive expertise,...

Meet our partner: Kevin Maresca from Pfizer

Meet our partner: Kevin Maresca from Pfizer

Kevin Maresca works in Early Clinical Development within Pfizer’s Worldwide Research, Development and Medical (WRDM) organization. He is head of PET/Molecular Imaging within the Digital Medicine and Translational Imaging group. We talked with Kevin about the role of...

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831514. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.